Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medipharm Labs Corp (TSX:LABS)

0.0650 -0.0050 (-7.14%)
Streaming Delayed Price Updated: 2:34 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medipharm Labs Corp

< Previous 1 2 Next >
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
From MediPharm Labs Corp.
Via GlobeNewswire
Apollo Capital Wins Proxy Contest at MediPharm Labs
From Apollo Technology Capital Corporation
Via GlobeNewswire
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
Shareholders Urged to Vote for Proven Strategy and Team, Reject Dissident’s Inadequate Plan and Nominees 
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
From MediPharm Labs Corp.
Via GlobeNewswire
Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis Company
From Apollo Technology Capital Corporation
Via GlobeNewswire
This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago
Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's the full recap. 
Via Benzinga
Topics Cannabis
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
From MediPharm Labs Corp.
Via GlobeNewswire
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
ISS concludes that Apollo “has not presented a compelling case for change” 
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
From MediPharm Labs Corp.
Via GlobeNewswire
Alleged Securities Fraud at MediPharm Labs Says Apollo Capital
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
From MediPharm Labs Corp.
Via GlobeNewswire
Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck’s Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
From MediPharm Labs Corp.
Via GlobeNewswire
Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting
From Apollo Technology Capital Corporation
Via GlobeNewswire
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
From MediPharm Labs Corp.
Via GlobeNewswire
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
From MediPharm Labs Corp.
Via GlobeNewswire
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024... 
Via Benzinga
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an... 
Via Benzinga
Topics Cannabis
This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,... 
Via Benzinga
Topics Cannabis
Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as... 
Via Benzinga
Topics Cannabis
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to... 
Via Benzinga
Topics Cannabis
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
Via Benzinga
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,... 
Via Benzinga
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products... 
Via Benzinga
Topics Cannabis
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and... 
Via Benzinga
Topics Cannabis
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.